Hamilton, MT, United States of America

Harlan D Caldwell

This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, The United States of America. Active years: 1984-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harlan D Caldwell. Retrieved from https://idiyas.com/inventor/harlan-d-caldwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1984-2019

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Harlan D Caldwell: Innovator in Chlamydia Vaccine Development

Introduction

Harlan D Caldwell is a notable inventor based in Hamilton, Montana, who has made significant contributions to the field of medical research, particularly in the development of vaccines for Chlamydia infections. With a total of nine patents to his name, Caldwell's work focuses on innovative compositions and methods aimed at treating and preventing Chlamydial infections.

Latest Patents

Caldwell's latest patents include a Chlamydia vaccine that discloses compositions and methods for the treatment of Chlamydial infection. The compositions provided include polypeptides that contain at least one antigenic portion of the antigen and DNA sequences encoding such polypeptides. Additionally, pharmaceutical compositions, vaccines, and diagnostic kits are also disclosed. Another significant patent is for an attenuated Chlamydia vaccine, which provides vectors, attenuated pathogens, compositions, methods, and kits for preventing or treating infections caused by infectious pathogens. This invention includes vectors comprising plasmid-encoded ppg genes while lacking ppg4, a regulator of virulence-associated genes. The application also discusses attenuated pathogens that are cured of their plasmid and have additional mutations to enhance attenuation, particularly mutations in the CT135 gene or in the tryptophan operon.

Career Highlights

Caldwell has worked with prestigious organizations, including the National Institutes of Health, a component of the U.S. Department of Health & Human Services, and The United States of America as represented by the Department of Health. His work in these institutions has allowed him to contribute significantly to public health and medical research.

Collaborations

Throughout his career, Caldwell has collaborated with esteemed colleagues, including Yuan Ying and You-Xun Zhang. These collaborations have furthered his research and development efforts in the field of infectious diseases.

Conclusion

Harlan D Caldwell's innovative work in the development of Chlamydia vaccines showcases his dedication to advancing medical science and improving public health. His contributions through patents and collaborations highlight the importance of research in combating infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…